We thank Becton Dickinson for the free supply of EDTA-gel (PPT) tubes.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999;285:169–72.10.1016/S0009-8981(99)00112-6Search in Google Scholar PubMed
2. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage laboratory medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007;116:95–8.10.1161/CIRCULATIONAHA.107.185266http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000248456000017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
3. Murdoch DR, Byrne J, Farmer R, Morton JJ. Disparity between studies of the stability of BNP in blood: comparison of endogenous and exogenous peptide. Heart 1999;81:212–3.10.1136/hrt.81.2.212Search in Google Scholar PubMed
4. Gobinet-Georges A, Valli N, Filliatre H, Dubernet MF, Dedeystere O, Bordenave L. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000;38:519–23.10.1515/CCLM.2000.076Search in Google Scholar PubMed
5. Santos H, Cauliez B, Tron C, Brunel V, Lavoinne A. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2? Clin Chem Lab Med 2010;48:399–401.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000274725300015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1515/CCLM.2010.069Search in Google Scholar PubMed
6. Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biological variation in the interpretation of results. Am Heart J 2006;152:828–34.10.1016/j.ahj.2006.08.021Search in Google Scholar PubMed
7. Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867–73.10.1373/clinchem.2003.026138Search in Google Scholar PubMed
8. Dupuy AM, Terrier N, Dubois M, Boularan AM, Cristol JP. Heparin plasma sampling as an alternative to EDTA for BNP determination on the Access-Beckman Coulter – effect of storage at −20 degrees C. Clin Lab 2006;52:393–7.Search in Google Scholar
9. Lippi G, Fortunato A, Salvagno GL, Montagnana M, Soffiati G, Guidi GC. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. J Clin Lab Anal 2007;21:293–7.10.1002/jcla.20187http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000250101300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed PubMed Central
10. Daves M, Pusceddu I, Cemin R. Measurement of type B natriuretic peptide in heparin and K(2) EDTA plasma. Clin Biochem 2010;43:483–4.10.1016/j.clinbiochem.2009.11.009http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000275219400022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
